This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Karin B. Nelson, MD; Judith K. Grether
National Institutes of Health Bethesda, Md

JAMA. 1997;278(18):1493.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—In their Letter, Dr Allred and colleagues¹ raise important methodologic considerations about the association between maternal treatment with magnesium sulfate and reduced risk of cerebral palsy (CP) in very low-birthweight children reported by Schendel et al² and previously by us³ for a cohort of children in northern California. Perhaps in Boston, Mass, magnesium first was used for tocolysis only after 1988, but that does not appear to be true in our study of the California cohort of children born in 1983 through 1985. Medical records for these births clearly indicate that magnesium was used for tocolysis in preterm labor in 57% of those who received magnesium.

We classified women in our study according to whether a clinical diagnosis of preeclampsia was reported in their medical records. In addition, we searched all medical records of patients who were admitted for delivery for evidence of blood . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?